Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Marimed (MRMD) over the last 14 years, with Q3 2025 value amounting to $2.1 million.

  • Marimed's Free Cash Flow rose 22007.94% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 12838.83%. This contributed to the annual value of -$5.2 million for FY2024, which is 5765.14% up from last year.
  • According to the latest figures from Q3 2025, Marimed's Free Cash Flow is $2.1 million, which was up 22007.94% from -$12000.0 recorded in Q2 2025.
  • In the past 5 years, Marimed's Free Cash Flow ranged from a high of $5.9 million in Q3 2023 and a low of -$10.1 million during Q2 2022
  • Moreover, its 5-year median value for Free Cash Flow was -$12000.0 (2025), whereas its average is $150105.3.
  • In the last 5 years, Marimed's Free Cash Flow surged by 135815.12% in 2021 and then plummeted by 41363.64% in 2023.
  • Over the past 5 years, Marimed's Free Cash Flow (Quarter) stood at $4.4 million in 2021, then tumbled by 109.54% to -$418000.0 in 2022, then crashed by 413.64% to -$2.1 million in 2023, then surged by 31.49% to -$1.5 million in 2024, then soared by 243.92% to $2.1 million in 2025.
  • Its Free Cash Flow was $2.1 million in Q3 2025, compared to -$12000.0 in Q2 2025 and $1.0 million in Q1 2025.